1. Introduction {#sec1}
===============

Bacteria which produce biofilms exhibit a significantly higher antimicrobial resistance and virulence than the planktonic forms \[[@bib1], [@bib2]\]. This suggests that antimicrobial resistance, biofilms and enhanced virulence might be related to each other. Although multiple mechanisms underlie the biofilm-associated enhancement of bacterial virulence and antimicrobial resistance the exact mechanisms are not understood well [@bib3].

*Yersinia enterocolitica* is a gastrointestinal enteric pathogen which causes a variety of diseases in humans [@bib4]. It can be classified into more than fifty serotypes and six biotypes, of which five (1B, 2, 3, 4, 5) have been considered pathogenic [@bib5]. Due to the absence of pYV (plasmid for *Yersinia* virulence) and major chromosomal virulence genes, strains of biotype 1A were initially considered non-pathogenic [@bib6]. However, strains of biotype 1A have been reported from clinical samples across the globe which indicates the pathogenic nature of these strains \[[@bib7], [@bib8]\]. Though, several studies have reported antimicrobial susceptibilities, virulence related genes and biofilm potential of many bacterial species, only a few have tried to discern the relationship between them in *Y. enterocolitica*. Further, information about a probable relationship between antimicrobial susceptibilities, virulence related genes and biofilm potential in *Y. enterocolitica* biotype 1A is scarce. Hence, in depth analysis of antimicrobial susceptibilities, virulence related genes and biofilm potential of *Y. enterocolitica* biotype 1A strains should be performed to understand the true pathogenic potential of these strains. Thus, the present study intended to study antimicrobial susceptibilities, virulence related genes and biofilm potential of *Y. enterocolitica* biotype 1A strains and, discern a relationship between them. Antimicrobial susceptibilities and biofilm potential of thirty strains of *Y. enterocolitica* biotype 1A were determined. The strains were isolated from various sources, like clinical samples, wastewater, pigs and pork. Though, the relationship between antimicrobials and biofilm formation has been studied in many members of the family *Enterobacteriaceae*, to the best of our knowledge, relationship between antimicrobials, biofilms and virulence has been reported in *Y. enterocolitica* biotype 1A strains for the first time.

2. Materials and methods {#sec2}
========================

2.1. Bacterial strains {#sec2.1}
----------------------

In the present study, 30 well-characterized strains of *Y. enterocolitica* biotype 1A were examined. These strains were authenticated and serotyped by the *Yersinia* National Reference Laboratory and WHO Collaborating Center, Pasteur Institute, Paris (France). These strains have also been deposited at the Pasteur Institute, Paris (France) and at the National Repository *i.e*. Microbial Type Culture Collection (MTCC) and Gene Bank located at Institute of Microbial Technology, Chandigarh, India. The strains were maintained in our laboratory at University of Delhi South Campus, New Delhi, India, on tryptone soy agar at 4°C. These strains have been isolated from various sources and genotyped using repetitive extragenic palindromic sequence (REP) and enterobacterial repetitive intergenic consensus sequence (ERIC) typing which revealed that these strains belonged to two clonal groups A or B [@bib9]. The details of these strains *viz.* laboratory accession numbers, serotypes, source of isolation and clonal groups are mentioned in [Table 2](#tbl2){ref-type="table"}. *Y. enterocolitica* subsp. *enterocolitica* strain ATCC® 23715™ was included as a reference strain.

2.2. Antimicrobial susceptibility testing {#sec2.2}
-----------------------------------------

Antimicrobial susceptibilities of *Y. enterocolitica* biotype 1A strains were determined by disk diffusion test following the guidelines of Clinical and Laboratory Standards Institute [@bib10]. Briefly, the bacteria were spread plated on Mac Conkey agar plate and the paper discs impregnated with different antibiotics were placed on the surface of agar plate. The plates were incubated at 37°C overnight and observed for the zone of inhibition (no bacterial growth) around the antibiotic disks. The diameter of the zone of inhibition around each antibiotic was measured and compared with a database of zone standards [@bib10] and accordingly the bacterial strains were designated as antibiotic susceptible, intermediate susceptible or resistant ([Fig. 1](#fig1){ref-type="fig"}). The antibiotic disks (HiMedia, India) which were used in the present study represented major antibiotic classes, like β-lactam antibiotic - amoxicillin (AMX), β-lactam+β-lactamase inhibitor combination - amoxicillin-clavulanate (AMC), a first generation cephalosporin -- cefazolin (CZ), a second generation cephalosporin - cefuroxime (CXM), third generation cephalosporins -- cefoperazone (CPZ), cefixime (CFM), a fourth generation cephalosporin -- cefepime (CPM) and a carbapenem -- imipenem (IPM). The β-lactams and cephalosporins kill bacteria by inhibiting the synthesis of bacterial cell wall. Quinolones (inhibit bacterial DNA replication) were represented by ciprofloxacin (CIP) and aminoglycosides (inhibit bacterial protein synthesis) by tobramycin (TOB), gentamycin (GEM), and kanamycin (K). Erythromycin (E) represented the macrolides (inhibit bacterial protein synthesis), and furazolidone (FR) represented the nitrofurans (inhibit many bacterial enzyme systems). The results were interpreted as per the guidelines of Clinical Laboratory Standards Institute, CLSI [@bib10]. The antibiotic susceptibility breakpoints suggested by CLSI in 2017 for most of the antibiotics are the same as in previous years, except for CPM, IPM and CZ [@bib10].Fig. 1Antimicrobial susceptibility testing of *Y. enterocolitica* biotype strains using disc diffusion test.Fig. 1

2.3. Assessment of biofilm formation {#sec2.3}
------------------------------------

Assessment of biofilm formation by *Y. enterocolitica* biotype 1A strains was performed in two different broth media *viz.* Mueller-Hinton broth (MHB) and Tryptone Soya broth (TSB) following the published protocols, with slight modifications [@bib11]. Briefly, 50 μl of overnight grown cultures at 28 °C with a cell density adjusted to 1 × 10^9^ cells/ml were inoculated in 1.5 ml polypropylene microcentrifuge tubes (Tarsons, USA) containing 1 ml of MHB and TSB respectively, and incubated further at 28 °C for 24 h and 48 h each, without shaking. The medium was removed after 24 h and 48 h, and the microcentrifuge tubes were dried at 55 °C for 30 min. One ml of 0.1 % crystal violet (prepared in isopropanol: methanol: phosphate buffered saline in the ratio of 1:1:18, v/v) was added to all microcentrifuge tubes and incubated at room temperature for 30 min. After this, crystal violet was removed, followed by two washings with 1 ml of sterile distilled water. Microcentrifuge tubes were further dried at 55 °C for 30 min. The dye bound to the biofilm was dissolved in a 200 μl mixture of ethanol and acetone (4:1 v/v) and 100 μl of this mixture was added to a 96-well microtiter plate. Optical density was measured at 540 nm using ELISA plate reader (Thermo Scientific, USA). The strains were classified as non-adherent, weakly, moderately or strongly adherent based upon the ODs of bacterial biofilms. The cut-off OD (ODc) was defined as three standard deviations above the mean OD of the negative control (0.20 ± 0.00 for MHB and 0.09 ± 0.00 for TSB). Strains were classified using the following criteria:

*Y. enterocolitica* strain ATCC® 23715™ was included as a positive control. The assay was performed for each isolate in biological and technical triplicates and the average result was reported. The statistical significance was calculated using the Mann-Whitney U-test with R statistical package. A p-value\<0.05 was considered as significant. A representative picture of the crystal violet assay has been presented as [Fig. 2](#fig2){ref-type="fig"}.Fig. 2A representative picture showing crystal violet bound to biofilms formed by various bacterial strains.Fig. 2

2.4. Virulence-related genes {#sec2.4}
----------------------------

Information about the distribution of several virulence-related genes encoding adhesion (*ail*), transcriptional factor (*virF*), invasion (*inv*), enterotoxin (*ystA, ystB, ystC*), subtilisin/kexin-like protease (*hreP*), streptogramin acetyltransferase (*sat*), fimbriae (*myfA*), enterochelin receptor protein (*fepA*), insecticidal toxin complex-like protein (*tccC*), enterochelin ABC transporter (*fepD*), enterochelin esterase (*fes*) and *Yersinia* modulator (*ymoA*) was retrieved from an earlier study published from our laboratory [@bib12].

3. Results and discussion {#sec3}
=========================

Results of antimicrobial susceptibility testing indicated that all the strains of biotype 1A were resistant to CZ - a first generation cephalosporin but sensitive to carbapenem - IPM, fluoroquinolone - CIP and an aminoglycoside-GEN ([Table 1](#tbl1){ref-type="table"}). The strains showed varied susceptibilities for other antibiotics. Among β-lactams, though only 8 (30%) strains were sensitive to AMX, a greater sensitivity (12 strains; 40%) was observed for β-lactam+β-lactamase inhibitor -- AMC. *Y. enterocolitica* biotype 1A strains showed a good level of susceptibility level for the second generation cephalosporin -- CXM, because 23 (76%) strains were sensitive to it. Biotype 1A strains showed different susceptibilities for the third generation cephalosporins -- CPZ and CFX. Most of them exhibited intermediate susceptibility for CPZ (19 strains; 63%) while only 4 strains (13%) were sensitive to CFM. The susceptibility of biotype 1A strains for the fourth generation cephalosporin was better than that for other cephalosporins, as 15 (50%) strains were susceptible. Most of the biotype 1A strains (27 strains; 90%) were susceptible to TOB and KAN. Susceptibility of biotype 1A strains for E and FR was less, only 5 (16%) strains were susceptible to E and, 11 (36%) strains were susceptible to FR.Table 1Antimicrobial susceptibilities of *Y. enterocolitica* biotype 1A strains.Table 1\
AntimicrobialAntimicrobial susceptibilitySensitive nIntermediate nResistant nAmoxycillin8319Amoxy-clavulanate12612Cefazolin\--30Cefuroxime2361Cefoperazone6195Cefixime4323Cefepime15510Imipenem30\--Ciprofloxacin30\--Tobramycin2712Gentamicin30\--Kanamycin28-2Erythromycin7221Furazolidone11-19[^2]Table 2Biofilm formation, virulence-related genes and clonal groups based on REP/ERIC typing in *Y. enterocolitica* biotype 1A.Table 2Virulence-related genes[c](#tbl2fnc){ref-type="table-fn"}Biofilm Formation(OD values) Mean ± SEM (BF [d](#tbl2fnd){ref-type="table-fn"})S. No.Strain number[a](#tbl2fna){ref-type="table-fn"}SerotypeSource of IsolationClonal group[b](#tbl2fnb){ref-type="table-fn"} (based on REP-ERIC typing)*ystB, hreP, satmyfA*fepAMH mediumTSB medium24 h48 h24 h48 h1.IP27359O:6,30--6,31Human stoolA+−+0.76 ± 0.05(M)0.77 ± 0.01(M)0.35 ± 0.01(M)0.36 ± 0.00(M)2.IP27360O:6,30--6,31Human stoolA+−−0.66 ± 0.12(M)0.69 ± 0.10(M)0.26 ± 0.02(M)0.56 ± 0.16(S)3.IP27362O:6,30--6,31Human stoolA+−−0.60 ± 0.11(M)1.02 ± 0.00(S)0.15 ± 0.01(W)0.31 ± 0.04(M)4.IP27363O:6,30--6,31Human stoolA+−−0.38 ± 0.02(W)0.68 ± 0.02(M)0.14 ± 0.01(W)0.34 ± 0.07(M)5.IP27364O:6,30--6,31Human stoolB−−+0.79 ± 0.20(M)0.81 ± 0.10(M)0.34 ± 0.01(M)0.35 ± 0.01(M)6.IP26311O:6,30--6,31Waste waterA+++0.39 ± 0.02(W)0.69 ± 0.02(M)0.36 ± 0.00(M)0.58 ± 0.09(S)7.IP26144O:6,30--6,31Waste waterA++−0.38 ± 0.03(W)0.41 ± 0.02(W)0.28 ± 0.05(M)0.34 ± 0.05(M)8.IP26145O:6,30--6,31Waste waterA++−0.39 ± 0.04(W)0.69 ± 0.04(M)0.14 ± 0.03(W)0.32 ± 0.09(M)9.IP27425O:6,30Human stoolA++−0.62 ± 0.05(M)0.64 ± 0.05(M)0.10 ± 0.01(W)0.14 ± 0.01(W)10.IP27431O:6,30Human stoolA+−−1.05 ± 0.12(S)1.06 ± 0.01(S)0.30 ± 0.06(M)0.36 ± 0.02(M)11.IP27433O:6,30Human stoolA++−0.40 ± 0.03(W)0.41 ± 0.01(W)0.30 ± 0.00(M)0.31 ± 0.00(M)12.IP27434O:6,30Human stoolA++−0.51 ± 0.05(M)1.10 ± 0.03(S)0.12 ± 0.03(W)0.28 ± 0.03(M)13.IP27481O:6,30Human stoolA+−−1.14 ± 0.16(S)1.17 ± 0.10(S)0.35 ± 0.08(M)0.36 ± 0.09(M)14.IP27404O:6,30Human stoolA++−1.23 ± 0.12(S)1.33 ± 0.10(S)0.15 ± 0.05(W)0.36 ± 0.05(M)15.IP27408O:6,30Human stoolA++−0.74 ± 0.12(M)1.24 ± 0.10(S)0.15 ± 0.06(W)0.26 ± 0.02(M)16.IP27426O:6,30Human stoolA+−−0.80 ± 0.06(M)1.12 ± 0.05(S)0.33 ± 0.07(M)0.29 ± 0.11(M)17.IP27428O:6,30Human stoolB−−+1.14 ± 0.18(S)1.18 ± 0.08(S)0.31 ± 0.10(M)0.59 ± 0.11(S)18.IP27430O:6,30Human stoolA+−−0.54 ± 0.03(M)1.13 ± 0.01(S)0.18 ± 0.01(W)0.64 ± 0.14(S)19.IP27432O:6,30Human stoolA++−0.50 ± 0.03(M)0.59 ± 0.03(M)0.28 ± 0.04(M)0.31 ± 0.10(M)20.IP27484O:6,30Human stoolB−−+0.58 ± 0.05(M)0.58 ± 0.05(M)0.33 ± 0.06(M)0.32 ± 0.03(M)21.IP26261O:10-34Waste waterB+++0.80 ± 0.12(M)0.82 ± 0.10(M)0.59 ± 0.05(S)0.61 ± 0.04(S)22.IP26147O:10-34Waste waterB−−+0.73 ± 0.04(M)1.15 ± 0.04(S)0.32 ± 0.08(M)0.32 ± 0.03(M)23.IP26316O:41,42Waste waterA+−+0.30 ± 0.04(W)0.32 ± 0.04(W)0.11 ± 0.03(W)0.15 ± 0.01(W)24.IP26151O:7,8-8-8,19Waste waterA+++1.02 ± 0.19(S)1.08 ± 0.09(S)0.36 ± 0.04(M)0.52 ± 0.00(S)25.IP26153O:7,8-8-8,19PorkB−−+0.80 ± 0.12(M)1.07 ± 0.12(S)0.31 ± 0.01(M)0.35 ± 0.02(M)26.-NDPig throatA+++0.81 ± 0.11(M)0.80 ± 0.11(M)0.34 ± 0.09(M)0.52 ± 0.00(S)27.-NDPig throatA++−1.02 ± 0.08(S)1.07 ± 0.05(S)0.36 ± 0.05(M)0.73 ± 0.14(S)28.IP27387NAGHuman stoolB−−+0.74 ± 0.05(M)1.40 ± 0.03(S)0.36 ± 0.11(M)0.33 ± 0.03(M)29.IP27388NAGHuman stoolA+++0.26 ± 0.02(W)0.80 ± 0.02(M)0.31 ± 0.09(M)0.35 ± 0.17(M)30.IP27485NAGHuman stoolA++−0.70 ± 0.12(M)0.79 ± 0.12(M)0.31 ± 0.04(M)0.61 ± 0.20(S)[^3][^4][^5][^6][^7]

Results of the crystal violet assay indicated that all biotype 1A strains were capable of producing biofilms, even when cells were not exposed to any external stress, like depletion of iron, carbon, nitrogen or low concentration of oxygen. In MHB medium, after an incubation of 24 h, 11 (36.7%) strains were classified as strong biofilm producers, 12 (40%) strains as moderate biofilm producers, and 7 (23.3%) strains as weak biofilm producers. While after 48 h incubation in MHB medium, 14 (46.7%) strains were classified as strong biofilm producers, 13 (43.3%) strains as moderate biofilm producers, and 3 (10%) strains as weak biofilm producers ([Table 2](#tbl2){ref-type="table"}). In TSB medium, after an incubation of 24 h, only 1 (3.3%) strain was strong biofilm producer, 20 (66.7%) strains were moderate biofilm producers, and 9 (30%) strains were weak biofilm producers. After incubation of 48 h in TSB medium, 9 (30%) strains were found to be strong biofilm producers, 19 (63.3%) strains were moderate biofilm producers, and 2 (6.7%) strains were weak biofilm producers. A significant improvement in the biofilm forming capability of biotype 1A strains was observed after 48 h of incubation, in either type of culture medium (p \< 0.05). The reference strain ATCC® 23715™ was found to be a moderate biofilm producer after 24 h incubation, but showed a strong biofilm forming potential after 48 h incubation, in both MHB and TSB. Thus, our results are in concordance with the results of earlier studies which reported that all strains of *Y. enterocolitica* produced biofilms \[[@bib13], [@bib14], [@bib15]\]. A recent study however, has reported that strains of *Y. enterocolitica* biotype 1A isolated from meat samples either did not produce, or were weak producers of biofilms [@bib8].

It was observed that those biotype 1A strains which were classified as weak biofilm producers were resistant to a β-lactam antibiotic - AMX, β-lactam and β-lactamase inhibitor combination -- AMC, and the first generation cephalosporin -- CZ. These strains however, displayed varied level of susceptibilities for other antibiotics. The strains classified as moderate or strong biofilm producers showed varied levels of susceptibility, exhibiting both sensitive and resistant phenotypes towards different antibiotics. A previous study reported also reported that biofilm forming *Y. enterocolitica* biotype 4 isolates were more resistant to antibiotics than the planktonic forms [@bib15]. However, in the present study, it was observed that biotype 1A strains showed a range of susceptibilities to different antibiotics. Such associations of antimicrobial susceptibilities and biofilm formation in *Y. enterocolitica* biotype 1A strains emphasized an earlier suggestion that *Y. enterocolitica* biotype 1A represented a heterogeneous population of more than one subspecies [@bib16].

Analysis of the biofilm forming potential of biotype 1A strains and genotyping using repetitive extragenic palindromic sequence (REP) and enterobacterial repetitive intergenic consensus sequence (ERIC) typing revealed an interesting observation. It was observed that, while REP/ERIC clonal group A was associated with weak, moderate and strong biofilm producers while strains strong and moderate biofilm producers belonged exclusively to the REP/ERIC clonal group B ([Table 2](#tbl2){ref-type="table"}). In an earlier study, it was reported that four virulence-associated genes *viz.* subtilisin/kexin-like protease (*hreP*), fimbriae (*myfA*), *Yersinia* stable toxin B (*ystB*), and streptogramin acetyltransferase (*sat*) were exclusively associated with strains of clonal group A [@bib12]. Thus, clonal group appears to encompass strains exhibiting a diverse biofilm potential greater number of virulence associated genes. more No co-relation was observed in the biofilm forming potential of biotype 1A strains and source of isolation (clinical versus nonclinical). Thus, it might be inferred that the biofilm forming potential of biotype 1A strains might be related to the clonal groups, rather than the source from which they were isolated. Various studies have shown that *Y. enterocolitica* biotype 1A was genetically the most heterogeneous biotype of *Y. enterocolitica*, encompassing strains of numerous serotypes \[[@bib17], [@bib18]\]. Thus, it becomes reasonable to assume that biofilm formation in biotype 1A might be a strain-specific character which cannot be extrapolated to all strains of the same biotype, serotype, source of isolation.

An earlier study reported that *Y. enterocolitica* biotype 1A strains lacked both the pYV plasmid and some virulence genes located on chromosome encoding adhesion (*ail*), fimbriae (*myfA*), enterotoxin (*ystA*), TTSS and HPI [@bib6]. However, biotype 1A strains have been associated with various food-borne outbreaks, indicating that these strains are pathogenic \[[@bib7], [@bib8]\]. An earlier study from our laboratory reported that certain virulence-related genes encoding adhesion (*ail*), transcriptional factor (*virF*), *Yersinia* stable toxins A and C (*ystA, ystC*) and, insecticidal toxin complex-like protein (*tccC*) were absent, while other virulence-related genes like *Yersinia* stable toxin B (*ystB*), subtilisin/kexin-like protease (*hreP*), streptogramin acetyltransferase (*sat*), fimbriae (*myfA*) and enterochelin receptor protein (*fepA*) were present in many strains of *Y. enterocolitica* biotype 1A [@bib12]. Also, it was reported that four virulence-associated genes *viz.* subtilisin/kexin-like protease (*hreP*), fimbriae (*myfA*), *Yersinia* stable toxin B (*ystB*), and streptogramin acetyltransferase (*sat*) were exclusively associated with strains of clonal group A [@bib12]. However, the results of the present study indicated that strong and moderate biofilm producers were associated with clonal group B.

The REP/ERIC-PCR based genotyping of *Y. enterocolitica* biotype 1A strains isolated from clinical and environmental sources revealed that despite the immense heterogeneity in the O-antigens, the strains clustered into limited clonal groups which suggest that there might be a limited genotypic diversity in biotype 1A strains studied [@bib9]. Our study failed to reveal an unequivocal relationship between antimicrobial susceptibilities, biofilm production and virulence-related genes. However, our results indicated that there was a relationship between clonal groups and biofilm forming potential of *Y. enterocolitica* biotype 1A strains, with REP/ERIC clonal group B associated with strains exhibiting strong and moderate biofilm forming potential and REP/ERIC clonal group A with weak, moderate and strong biofilm producers. Also, it was observed that the biofilm potential of biotype 1A strains investigated in this study was different from biotype 1A strains isolated from other parts of the world [@bib8]. These differences might be attributed to the heterogeneous nature of biotype 1A strains isolated from different parts of the world. However, further studies using serotypes of biotype 1A not represented in the present study are required to corroborate these findings and unravel the true virulence potential of biotype 1A strains.
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